Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

I am seeing some signs of a Google search ranking update over the past day or so but the chatter is super limited right now. Many of the tools spike yesterday but like I said, the SEO community ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Recursion Pharmaceuticals currently has the industry's largest AI supercomputer. It also has partnerships with major drugmakers, but these have yet to yield major wins. Recursion'a lack of clinical ...

The original version of this story appeared in Quanta Magazine. If you want to solve a tricky problem, it often helps to get organized. You might, for example, break the problem into pieces and tackle ...

Meta announced on Tuesday a new Facebook algorithm update that will showcase more Reels videos tailored to users’ preferences. The update includes features that offer users greater control over the ...

Facebook's vice president of product, Jagjit Chawla, talks about how the platform treats AI-generated content and how you can see less of it. Katelyn is a writer with CNET covering artificial ...

On a scorching July afternoon in Shanghai, dozens of Chinese students hunch over tablet screens, engrossed in English, math and physics lessons. Algorithms track every keystroke, and the seconds spent ...

How do the algorithms that populate our social media feeds actually work? In a piece for Time Magazine excerpted from his recent book Robin Hood Math, Noah Giansiracusa sheds light on the algorithms ...

RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. Nvidia made early investors rich, but there is a new class ...